Supplementary Figure from Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial
Kaspar Draaisma(Utrecht University), Pim J. French(Erasmus MC Cancer Institute), Pierre A. Robe(University Medical Center Utrecht), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Michael Weller(University Hospital of Zurich), Iris de Heer(Erasmus MC Cancer Institute), Filip De Vos(University Medical Center Utrecht), Martin Klein(Amsterdam University Medical Centers), Corneel Coens(European Organisation for Research and Treatment of Cancer), Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Antje Wick(Heidelberg University), Tina Verschuere(KU Leuven), Marion Smits(Erasmus MC), Paul Mulholland(University College London Hospitals NHS Foundation Trust), Martin Taphoorn(Leiden University Medical Center), Johan M. Kros(Erasmus MC), Olivier Chinot(Aix-Marseille Université), C. Mircea S. Tesileanu(Erasmus MC Cancer Institute), Ahmed Idbaïh(Centre National de la Recherche Scientifique), Paul M. Clément(Universitair Ziekenhuis Leuven), Vassilis Golfinopoulos(Champalimaud Foundation), Martin J. van den Bent(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia
|Magnetic Resonance in Medicine|2014|2.2k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k